Ahlskog JE - Search Results

1

Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?

Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Craig UK, Maraganore DM, Lennon VA, Kurland LT. Ahlskog JE, et al. Neurology. 1997 May;48(5):1356-62. doi: 10.1212/wnl.48.5.1356. Neurology. 1997. PMID: 9153473

2

Hemimasticatory spasm: clinical and electrophysiologic observations.

Auger RG, Litchy WJ, Cascino TL, Ahlskog JE. Auger RG, et al. Among authors: ahlskog je. Neurology. 1992 Dec;42(12):2263-6. doi: 10.1212/wnl.42.12.2263. Neurology. 1992. PMID: 1461376

3

Movement disorders as sequelae of central pontine myelinolysis: report of three cases.

Maraganore DM, Folger WN, Swanson JW, Ahlskog JE. Maraganore DM, et al. Among authors: ahlskog je. Mov Disord. 1992;7(2):142-8. doi: 10.1002/mds.870070208. Mov Disord. 1992. PMID: 1584236 Review.

4

Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.

Ahlskog JE, Tyce GM, Kelly PJ, van Heerden JA, Stoddard SL, Carmichael SW. Ahlskog JE, et al. Exp Neurol. 1989 Aug;105(2):152-61. doi: 10.1016/0014-4886(89)90114-3. Exp Neurol. 1989. PMID: 2753115

5

Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.

Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Ahlskog JE, et al. Neurology. 1995 Jul;45(7):1340-4. doi: 10.1212/wnl.45.7.1340. Neurology. 1995. PMID: 7617195

6

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Collins SJ, et al. Among authors: ahlskog je. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):167-73. doi: 10.1136/jnnp.58.2.167. J Neurol Neurosurg Psychiatry. 1995. PMID: 7876846 Free PMC article.

7

Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.

Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Britton JW, et al. Among authors: ahlskog je. Neurology. 1995 Mar;45(3 Pt 1):443-7. doi: 10.1212/wnl.45.3.443. Neurology. 1995. PMID: 7898693 Free article.

8

Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.

Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Ahlskog JE, et al. Arch Neurol. 1994 Dec;51(12):1236-41. doi: 10.1001/archneur.1994.00540240080020. Arch Neurol. 1994. PMID: 7986180 Clinical Trial.

9

Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.

Lieberman A, Imke S, Muenter M, Wheeler K, Ahlskog JE, Matsumoto JY, Maraganore DM, Wright KF, Schoenfelder J. Lieberman A, et al. Among authors: ahlskog je. Neurology. 1993 Oct;43(10):1981-4. doi: 10.1212/wnl.43.10.1981. Neurology. 1993. PMID: 8105422 Clinical Trial.

10

Idiopathic intracranial hypertension.

Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Radhakrishnan K, et al. Among authors: ahlskog je. Mayo Clin Proc. 1994 Feb;69(2):169-80. doi: 10.1016/s0025-6196(12)61045-3. Mayo Clin Proc. 1994. PMID: 8309269 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters